Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 8Polycystic Ovary Syndrome 7Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Colorectal Neoplasms 5Lung Neoplasms 4Metabolic Syndrome 3Insulin Resistance 3Adenocarcinoma of Lung 3Lymphoma, Large B-Cell, Diffuse 2Glioblastoma 2Carcinoma, Renal Cell 2pCR Rate 1Weight Gain 1Thyroid Diseases 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Lymphoma 1Leukoplakia 1Leukemia, Myelomonocytic, Acute 1

Interventions

Cytarabine 10Mitoxantrone 6Peripheral Blood Stem Cell Transplantation 3Idarubicin 3Filgrastim 3Etoposide 3Busulfan 3fludarabine phosphate 2Vorinostat 2Tacrolimus 2Methotrexate 2Decitabine 2Daunorubicin 2Cyclophosphamide 2Bortezomib 2tanespimycin 1pegylated granulocyte colony-stimulating factor 1ixazomib 1entinostat 1eltrombopag 1choline magnesium trisalicylate 1alvocidib 1Stem Cell Transplantation 1Sorafenib 1Proteasome Inhibitors 1Pravastatin 1Mycophenolic Acid 1Metformin 1Liposomes 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Monocytic, Acute × Metformin × Clear all
NCT01849276 2019-01-31

Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML

Northwestern University

Phase 1 Terminated
2 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡